Google Readertag:google.com,2005:reader/user/15029568296969101907/label/Life Science Co. TweetsCIGBmPHOrbACSDBN2012-06-02T01:24:42Zsmscotweetshttp://feedburner.google.comtag:google.com,2005:reader/item/da2516ff1146bc6f2012-06-02T01:07:18Z2012-06-02T01:07:18Z

Accelrys: RT @RandDMagazine Diagnostic labs analyze from bugs to toenails | R&amp;D Mag http://t.co/6S3nTNHw<img src="http://feeds.feedburner.com/~r/smscotweets/~4/60uB1_u_7Dc" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/43937824.rsshttp://twitter.com/Accelrys/statuses/208726448947732482tag:google.com,2005:reader/item/3351d3b9d979698c2012-06-02T01:06:37Z2012-06-02T01:06:37Z

Accelrys: RT @RandDMagazine New lab turns SD gold town into scientific hub | R&amp;D Mag http://t.co/Se1xTz74<img src="http://feeds.feedburner.com/~r/smscotweets/~4/TL2TD41IfYI" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/43937824.rsshttp://twitter.com/Accelrys/statuses/208726280340897794tag:google.com,2005:reader/item/3e0a99bd05bba03d2012-06-02T01:02:28Z2012-06-02T01:02:28Z

Accelrys: PharmaLive: Talon Therapeutics Announces Enrollment and Dosing of the First Patient in the Phase 3.. http://t.co/qd8aWyPE<img src="http://feeds.feedburner.com/~r/smscotweets/~4/HKb7s52HUdQ" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/43937824.rsshttp://twitter.com/Accelrys/statuses/208725236374446081tag:google.com,2005:reader/item/b3ddc5df845f42072012-06-02T01:01:05Z2012-06-02T01:01:05Z

Accelrys: PharmaLive: Onconova Presents Clinical Trial Data for Oral Rigosertib at ASCO Annual Meeting http://t.co/3Lrf719u<img src="http://feeds.feedburner.com/~r/smscotweets/~4/tzOnS_fmLXQ" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/43937824.rsshttp://twitter.com/Accelrys/statuses/208724885671919618tag:google.com,2005:reader/item/ad14fdcafac1dfae2012-06-02T01:00:18Z2012-06-02T01:00:18Z

Accelrys: PharmaLive: Genzyme Reports Positive Top-Line Results of TOWER, a Pivotal Phase III Trial for Auba.. http://t.co/8q2BGPmP<img src="http://feeds.feedburner.com/~r/smscotweets/~4/Zwc-5H6dluA" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/43937824.rsshttp://twitter.com/Accelrys/statuses/208724688606736384tag:google.com,2005:reader/item/a2ee977bc000eaec2012-06-01T22:02:34Z2012-06-01T22:02:34Z

MicroConstants: .@TheScientistLLC Announces the Finalists of their 10th Annual Best Places to Work in Industry Survey http://t.co/HYE1n5FV<img src="http://feeds.feedburner.com/~r/smscotweets/~4/fOadlhzGcgY" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/30062649.rsshttp://twitter.com/MicroConstants/statuses/208679961874284544tag:google.com,2005:reader/item/134d745bf2eaae5f2012-06-01T22:00:44Z2012-06-01T22:00:44Z

promega: "Want Your Kids to Eat Their Vegetables? Start Them Early and Give Them Water", results from recent research (blog): http://t.co/I2JM8s7Y<img src="http://feeds.feedburner.com/~r/smscotweets/~4/sDIt3iN-QRM" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/8814152.rsshttp://twitter.com/promega/statuses/208679501499088896tag:google.com,2005:reader/item/fbb876e6200e32012012-06-01T21:45:02Z2012-06-01T21:45:02Z

Accelrys: House stamps approval on fast-track approach to drug development http://t.co/mxMdOZBN via @JohnCFierce<img src="http://feeds.feedburner.com/~r/smscotweets/~4/KlC-yIuGo98" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/43937824.rsshttp://twitter.com/Accelrys/statuses/208675550531825665tag:google.com,2005:reader/item/ca3c376cecee3bd52012-06-01T20:53:21Z2012-06-01T20:53:21Z

Accelrys: Learn how Unilever rapidly searches the PubMed database for research. Register now: https://t.co/LC8y5bUq<img src="http://feeds.feedburner.com/~r/smscotweets/~4/umSFG6ZQR3o" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/43937824.rsshttp://twitter.com/Accelrys/statuses/208662542980096001tag:google.com,2005:reader/item/98cc30e2d00dd4412012-06-01T20:50:02Z2012-06-01T20:50:02Z

Accelrys: The 2012 Accelrys Asia-Pacific User Group Meetings continue next week in Seoul, South Korea on June 5! http://t.co/Qlxj0qf8 #ACCLUGM<img src="http://feeds.feedburner.com/~r/smscotweets/~4/UekoJGjZjDw" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/43937824.rsshttp://twitter.com/Accelrys/statuses/208661709236338688tag:google.com,2005:reader/item/993f160ea0d877062012-06-01T19:41:02Z2012-06-01T19:41:02Z

idtdna: DNA-wrangling robot performs 200,000 experiments a week http://t.co/BUH19GFX<img src="http://feeds.feedburner.com/~r/smscotweets/~4/HZL4KLw6UBo" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/28173220.rsshttp://twitter.com/idtdna/statuses/208644342859038720tag:google.com,2005:reader/item/774321abc193b6732012-06-01T19:56:18Z2012-06-01T19:56:18Z

Accelrys: Learning to collaborate with Accelrys http://t.co/BTb7wTNn via http://t.co/I9pntyDV<img src="http://feeds.feedburner.com/~r/smscotweets/~4/9BXmy3bwhFk" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/43937824.rsshttp://twitter.com/Accelrys/statuses/208648186624081920tag:google.com,2005:reader/item/cb7f650b1c366a9e2012-06-01T19:26:56Z2012-06-01T19:26:56Z

MicroConstants: Visit us at one of the CACO meetings next week on bioanalytical method validation &amp; regulated bioanalysis http://t.co/cEamfKYp<img src="http://feeds.feedburner.com/~r/smscotweets/~4/VcJPXxxyXTE" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/30062649.rsshttp://twitter.com/MicroConstants/statuses/208640793878085632tag:google.com,2005:reader/item/a4e95bb603bef14c2012-06-01T17:58:34Z2012-06-01T17:58:34Z

Accesspharma: @jnfuhrman True - check out MuGard for oral mucositis side effect ... http://t.co/To6yuTcw ... #palliative #pain<img src="http://feeds.feedburner.com/~r/smscotweets/~4/aecqDZA0m8w" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/38986882.rsshttp://twitter.com/Accesspharma/statuses/208618557788008450tag:google.com,2005:reader/item/6b2e9c13fd5a277b2012-06-01T17:59:39Z2012-06-01T17:59:39Z

idtdna: RT @bigthink: Rosalind Franklin&#39;s contribution to Crick &amp; Watson&#39;s Nobel-winning DNA discovery explored in film starring Rachel Weis ...<img src="http://feeds.feedburner.com/~r/smscotweets/~4/gD7dwwNRAhM" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/28173220.rsshttp://twitter.com/idtdna/statuses/208618827620159488tag:google.com,2005:reader/item/fbc0e09daa3dc86f2012-06-01T17:57:53Z2012-06-01T17:57:53Z

Accesspharma: RT @jnfuhrman: Palliative care is part of late-stage cancer treatment http://t.co/wdUUSJpw #hpm #ASCO12<img src="http://feeds.feedburner.com/~r/smscotweets/~4/o9TjP-KDc1M" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/38986882.rsshttp://twitter.com/Accesspharma/statuses/208618385016242177tag:google.com,2005:reader/item/718d94c053ea88712012-06-01T17:57:08Z2012-06-01T17:57:08Z

Accesspharma: Afinitor and MuGard ... perfect together (for oral mucositis, of course)<img src="http://feeds.feedburner.com/~r/smscotweets/~4/26jUbfvAcQg" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/38986882.rsshttp://twitter.com/Accesspharma/statuses/208618196964614144tag:google.com,2005:reader/item/17eb41b74b0a713d2012-06-01T17:56:47Z2012-06-01T17:56:47Z

Accesspharma: RT @FiercePharma: Novartis preps for #ASCO12 data on Afinitor (breast cancer), Tasigna (CML) http://t.co/qcBbIXsa $NVS #pharma<img src="http://feeds.feedburner.com/~r/smscotweets/~4/cMrDKKeLr_M" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/38986882.rsshttp://twitter.com/Accesspharma/statuses/208618106636087296tag:google.com,2005:reader/item/744d0f345eca37682012-06-01T17:56:44Z2012-06-01T17:56:44Z

Accesspharma: RT @LungCancer_OW: Novartis to showcase oncology portfolio at ASCO: Results to cover Afinitor and Tasigna plus early pipeline produ... h ...<img src="http://feeds.feedburner.com/~r/smscotweets/~4/4U1a2iqPScY" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/38986882.rsshttp://twitter.com/Accesspharma/statuses/208618093776347136tag:google.com,2005:reader/item/298bbc33a673af7f2012-06-01T17:56:41Z2012-06-01T17:56:41Z

Accesspharma: RT @StephenHDunn: Novartis preps for #ASCO12 data on Tasigna, Afinitor - FiercePharma http://t.co/2JDSCXjY<img src="http://feeds.feedburner.com/~r/smscotweets/~4/Uxct-8dZAjw" height="1" width="1"/>

(author unknown)tag:google.com,2005:reader/feed/http://twitter.com/statuses/user_timeline/38986882.rsshttp://twitter.com/Accesspharma/statuses/208618084041359362